Increasing Prevalence Of Urinary Stones Around The Globe Has Fueled The Growth Of The Urolithiasis Management Devices Market


Urolithiasis Management Devices Market

 Urolithiasis management devices are used to treat urinary tract infections and more. The main aim of these products is to promote healthy and rapid healing for the patients, by providing soothing relief to the affected areas, and preventing further damage to the patient. The main cause of this disease is a bacterial infection called Urtica dioica, which affects the large intestine of the body. This disease is extremely painful and may also affect other organs of the body.

The growing prevalence and incidence of urinary stones is a prime factor driving the growth of the urolithiasis management devices market. According to the World Health Organization, the prevalence of upper urinary tract stones (renal and ureteric) was high in both children (33/39, 84.6%) and adults (117/145, 80.7%). In adults, there was a higher prevalence of bladder stones in males (15.2%) than in females (2.1%), a ratio of 7.2:1. Also, increasing preferences for non-invasive surgeries are again projected to foster the growth of the urolithiasis management devices market. The invention of non-invasive techniques has also given rise to new treatments like urolithiasis management devices, that can help reduce or eliminate this disease completely, without any complications. The increasing geriatric population coupled with the advancement in technology is further projected to augment the market growth.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing healthcare spending by the regional government. According to the U.S. Centers for Medicare & Medicaid Services, the U.S. health care spending grew 4.6 percent in 2019, reaching $3.8 trillion or $11,582 per person.  As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent. Also, there is a high prevalence rate of urinary stones in the region which is again driving the regional market growth.

Key Developments:

1.      In September 2019, Dornier MedTech (Dornier), a global urology company in kidney stone management, launched the new OptiVision technology for the Dornier Delta® III at the German Urology Congress (DGU) 2019 in Hamburg from 18-20 September 2019.

2.      In September 2018, Boston Scientific Corporation announced the global launch of the LithoVue Empower™ Retrieval Deployment Device, designed to be used with the LithoVue™ Single-Use Digital Flexible Ureteroscope and compatible nitinol retrieval basket to enable urologists to operate an ureteroscope and basket simultaneously when retrieving kidney stones via flexible ureteroscopy (URS).

3.      In June 2020, Olympus has launched a new laser platform intended for soft tissue applications and for lithotripsy, the destruction of hard masses within the body including in particular kidney stones. 

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)